0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Vaccine Delivery Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-24N15051
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Oral Vaccine Delivery Market Research Report 2023
BUY CHAPTERS

Global Oral Vaccine Delivery Market Research Report 2025

Code: QYRE-Auto-24N15051
Report
May 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oral Vaccine Delivery Market Size

The global market for Oral Vaccine Delivery was valued at US$ 2761 million in the year 2024 and is projected to reach a revised size of US$ 3943 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Oral Vaccine Delivery Market

Oral Vaccine Delivery Market

Oral vaccines have several attractive features compared with parenteral vaccines, but studies on their use have been limited almost exclusively to protection against mucosally transmitted pathogens.
The oral vaccination market is primarily driven by the advantages it offers in terms of ease of administration, increased patient compliance, and cost-effectiveness compared to traditional injectable vaccines. Oral vaccines provide a non-invasive and painless immunization method, particularly beneficial for pediatric and elderly populations. Additionally, their potential to elicit both systemic and mucosal immunity enhances protection against pathogens that enter the body through mucosal surfaces, such as the respiratory and gastrointestinal tracts, further fueling their adoption. However, the market also faces challenges, including the complex formulation and delivery of oral vaccines, which may affect their stability and efficacy. Developing vaccines that can withstand acidic environments and enzymatic degradation in the gastrointestinal tract poses significant scientific and manufacturing challenges. Moreover, gaining regulatory approvals and ensuring public acceptance of oral vaccines may require extensive clinical data and educational efforts to dispel misconceptions about their safety and efficacy. To overcome these challenges, the industry is focused on research and innovation to improve oral vaccine formulation and delivery technologies. Collaborations between vaccine developers, research institutions, and regulatory authorities are crucial in driving the growth of the oral vaccination market and expanding access to effective and accessible immunization options, particularly in regions with limited healthcare infrastructure.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Vaccine Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccine Delivery.
The Oral Vaccine Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Vaccine Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Vaccine Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oral Vaccine Delivery Market Report

Report Metric Details
Report Name Oral Vaccine Delivery Market
Accounted market size in year US$ 2761 million
Forecasted market size in 2031 US$ 3943 million
CAGR 5.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Public
  • Private
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oral Vaccine Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oral Vaccine Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Oral Vaccine Delivery Market growing?

Ans: The Oral Vaccine Delivery Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Oral Vaccine Delivery Market size in 2031?

Ans: The Oral Vaccine Delivery Market size in 2031 will be US$ 3943 million.

Who are the main players in the Oral Vaccine Delivery Market report?

Ans: The main players in the Oral Vaccine Delivery Market are Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals

What are the Application segmentation covered in the Oral Vaccine Delivery Market report?

Ans: The Applications covered in the Oral Vaccine Delivery Market report are Public, Private

What are the Type segmentation covered in the Oral Vaccine Delivery Market report?

Ans: The Types covered in the Oral Vaccine Delivery Market report are Rotavirus Vaccine, Cholera Vaccine, Oral Polio Vaccine, Other

Recommended Reports

Oral Vaccine Markets

Pediatric and Flu Vaccines

Vaccine Adjuvants & Accessories

1 Oral Vaccine Delivery Market Overview
1.1 Product Definition
1.2 Oral Vaccine Delivery by Type
1.2.1 Global Oral Vaccine Delivery Market Value Comparison by Type (2024 VS 2031)
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.2.5 Other
1.3 Oral Vaccine Delivery by Application
1.3.1 Global Oral Vaccine Delivery Market Value by Application (2024 VS 2031)
1.3.2 Public
1.3.3 Private
1.4 Global Oral Vaccine Delivery Market Size Estimates and Forecasts
1.4.1 Global Oral Vaccine Delivery Revenue 2020-2031
1.4.2 Global Oral Vaccine Delivery Sales 2020-2031
1.4.3 Global Oral Vaccine Delivery Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oral Vaccine Delivery Market Competition by Manufacturers
2.1 Global Oral Vaccine Delivery Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oral Vaccine Delivery Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oral Vaccine Delivery Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oral Vaccine Delivery, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Vaccine Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Vaccine Delivery, Product Type & Application
2.7 Global Key Manufacturers of Oral Vaccine Delivery, Date of Enter into This Industry
2.8 Global Oral Vaccine Delivery Market Competitive Situation and Trends
2.8.1 Global Oral Vaccine Delivery Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oral Vaccine Delivery Players Market Share by Revenue
2.8.3 Global Oral Vaccine Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Vaccine Delivery Market Scenario by Region
3.1 Global Oral Vaccine Delivery Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oral Vaccine Delivery Sales by Region: 2020-2031
3.2.1 Global Oral Vaccine Delivery Sales by Region: 2020-2025
3.2.2 Global Oral Vaccine Delivery Sales by Region: 2026-2031
3.3 Global Oral Vaccine Delivery Revenue by Region: 2020-2031
3.3.1 Global Oral Vaccine Delivery Revenue by Region: 2020-2025
3.3.2 Global Oral Vaccine Delivery Revenue by Region: 2026-2031
3.4 North America Oral Vaccine Delivery Market Facts & Figures by Country
3.4.1 North America Oral Vaccine Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oral Vaccine Delivery Sales by Country (2020-2031)
3.4.3 North America Oral Vaccine Delivery Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Vaccine Delivery Market Facts & Figures by Country
3.5.1 Europe Oral Vaccine Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oral Vaccine Delivery Sales by Country (2020-2031)
3.5.3 Europe Oral Vaccine Delivery Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Vaccine Delivery Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Vaccine Delivery Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oral Vaccine Delivery Sales by Region (2020-2031)
3.6.3 Asia Pacific Oral Vaccine Delivery Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Vaccine Delivery Market Facts & Figures by Country
3.7.1 Latin America Oral Vaccine Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oral Vaccine Delivery Sales by Country (2020-2031)
3.7.3 Latin America Oral Vaccine Delivery Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Vaccine Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Vaccine Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oral Vaccine Delivery Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oral Vaccine Delivery Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Vaccine Delivery Sales by Type (2020-2031)
4.1.1 Global Oral Vaccine Delivery Sales by Type (2020-2025)
4.1.2 Global Oral Vaccine Delivery Sales by Type (2026-2031)
4.1.3 Global Oral Vaccine Delivery Sales Market Share by Type (2020-2031)
4.2 Global Oral Vaccine Delivery Revenue by Type (2020-2031)
4.2.1 Global Oral Vaccine Delivery Revenue by Type (2020-2025)
4.2.2 Global Oral Vaccine Delivery Revenue by Type (2026-2031)
4.2.3 Global Oral Vaccine Delivery Revenue Market Share by Type (2020-2031)
4.3 Global Oral Vaccine Delivery Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oral Vaccine Delivery Sales by Application (2020-2031)
5.1.1 Global Oral Vaccine Delivery Sales by Application (2020-2025)
5.1.2 Global Oral Vaccine Delivery Sales by Application (2026-2031)
5.1.3 Global Oral Vaccine Delivery Sales Market Share by Application (2020-2031)
5.2 Global Oral Vaccine Delivery Revenue by Application (2020-2031)
5.2.1 Global Oral Vaccine Delivery Revenue by Application (2020-2025)
5.2.2 Global Oral Vaccine Delivery Revenue by Application (2026-2031)
5.2.3 Global Oral Vaccine Delivery Revenue Market Share by Application (2020-2031)
5.3 Global Oral Vaccine Delivery Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Oral Vaccine Delivery Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Oral Vaccine Delivery Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Oral Vaccine Delivery Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Lanzhou Institute
6.4.1 Lanzhou Institute Company Information
6.4.2 Lanzhou Institute Description and Business Overview
6.4.3 Lanzhou Institute Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lanzhou Institute Oral Vaccine Delivery Product Portfolio
6.4.5 Lanzhou Institute Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Company Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Serum Institute Oral Vaccine Delivery Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 Valneva
6.6.1 Valneva Company Information
6.6.2 Valneva Description and Business Overview
6.6.3 Valneva Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Valneva Oral Vaccine Delivery Product Portfolio
6.6.5 Valneva Recent Developments/Updates
6.7 Shanghai United Cell
6.7.1 Shanghai United Cell Company Information
6.7.2 Shanghai United Cell Description and Business Overview
6.7.3 Shanghai United Cell Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shanghai United Cell Oral Vaccine Delivery Product Portfolio
6.7.5 Shanghai United Cell Recent Developments/Updates
6.8 Bibcol
6.8.1 Bibcol Company Information
6.8.2 Bibcol Description and Business Overview
6.8.3 Bibcol Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bibcol Oral Vaccine Delivery Product Portfolio
6.8.5 Bibcol Recent Developments/Updates
6.9 PaxVax
6.9.1 PaxVax Company Information
6.9.2 PaxVax Description and Business Overview
6.9.3 PaxVax Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.9.4 PaxVax Oral Vaccine Delivery Product Portfolio
6.9.5 PaxVax Recent Developments/Updates
6.10 Vabiotech
6.10.1 Vabiotech Company Information
6.10.2 Vabiotech Description and Business Overview
6.10.3 Vabiotech Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Vabiotech Oral Vaccine Delivery Product Portfolio
6.10.5 Vabiotech Recent Developments/Updates
6.11 Tiantan Biological
6.11.1 Tiantan Biological Company Information
6.11.2 Tiantan Biological Description and Business Overview
6.11.3 Tiantan Biological Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Tiantan Biological Oral Vaccine Delivery Product Portfolio
6.11.5 Tiantan Biological Recent Developments/Updates
6.12 EuBiologics
6.12.1 EuBiologics Company Information
6.12.2 EuBiologics Description and Business Overview
6.12.3 EuBiologics Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.12.4 EuBiologics Oral Vaccine Delivery Product Portfolio
6.12.5 EuBiologics Recent Developments/Updates
6.13 Panacea Biotec Ltd
6.13.1 Panacea Biotec Ltd Company Information
6.13.2 Panacea Biotec Ltd Description and Business Overview
6.13.3 Panacea Biotec Ltd Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Panacea Biotec Ltd Oral Vaccine Delivery Product Portfolio
6.13.5 Panacea Biotec Ltd Recent Developments/Updates
6.14 Bio-Med
6.14.1 Bio-Med Company Information
6.14.2 Bio-Med Description and Business Overview
6.14.3 Bio-Med Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bio-Med Oral Vaccine Delivery Product Portfolio
6.14.5 Bio-Med Recent Developments/Updates
6.15 Halfkin Bio-Pharmaceuticals
6.15.1 Halfkin Bio-Pharmaceuticals Company Information
6.15.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Product Portfolio
6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Vaccine Delivery Industry Chain Analysis
7.2 Oral Vaccine Delivery Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Vaccine Delivery Production Mode & Process Analysis
7.4 Oral Vaccine Delivery Sales and Marketing
7.4.1 Oral Vaccine Delivery Sales Channels
7.4.2 Oral Vaccine Delivery Distributors
7.5 Oral Vaccine Delivery Customer Analysis
8 Oral Vaccine Delivery Market Dynamics
8.1 Oral Vaccine Delivery Industry Trends
8.2 Oral Vaccine Delivery Market Drivers
8.3 Oral Vaccine Delivery Market Challenges
8.4 Oral Vaccine Delivery Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Oral Vaccine Delivery Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oral Vaccine Delivery Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oral Vaccine Delivery Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oral Vaccine Delivery Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Oral Vaccine Delivery Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oral Vaccine Delivery Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oral Vaccine Delivery Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oral Vaccine Delivery Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oral Vaccine Delivery, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oral Vaccine Delivery, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oral Vaccine Delivery, Product Type & Application
 Table 12. Global Key Manufacturers of Oral Vaccine Delivery, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oral Vaccine Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Vaccine Delivery as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral Vaccine Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oral Vaccine Delivery Sales by Region (2020-2025) & (K Units)
 Table 18. Global Oral Vaccine Delivery Sales Market Share by Region (2020-2025)
 Table 19. Global Oral Vaccine Delivery Sales by Region (2026-2031) & (K Units)
 Table 20. Global Oral Vaccine Delivery Sales Market Share by Region (2026-2031)
 Table 21. Global Oral Vaccine Delivery Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oral Vaccine Delivery Revenue Market Share by Region (2020-2025)
 Table 23. Global Oral Vaccine Delivery Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oral Vaccine Delivery Revenue Market Share by Region (2026-2031)
 Table 25. North America Oral Vaccine Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oral Vaccine Delivery Sales by Country (2020-2025) & (K Units)
 Table 27. North America Oral Vaccine Delivery Sales by Country (2026-2031) & (K Units)
 Table 28. North America Oral Vaccine Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oral Vaccine Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oral Vaccine Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oral Vaccine Delivery Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Oral Vaccine Delivery Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Oral Vaccine Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oral Vaccine Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oral Vaccine Delivery Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oral Vaccine Delivery Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Oral Vaccine Delivery Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Oral Vaccine Delivery Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oral Vaccine Delivery Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oral Vaccine Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oral Vaccine Delivery Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Oral Vaccine Delivery Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Oral Vaccine Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oral Vaccine Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oral Vaccine Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oral Vaccine Delivery Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Oral Vaccine Delivery Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Oral Vaccine Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oral Vaccine Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oral Vaccine Delivery Sales (K Units) by Type (2020-2025)
 Table 51. Global Oral Vaccine Delivery Sales (K Units) by Type (2026-2031)
 Table 52. Global Oral Vaccine Delivery Sales Market Share by Type (2020-2025)
 Table 53. Global Oral Vaccine Delivery Sales Market Share by Type (2026-2031)
 Table 54. Global Oral Vaccine Delivery Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oral Vaccine Delivery Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oral Vaccine Delivery Revenue Market Share by Type (2020-2025)
 Table 57. Global Oral Vaccine Delivery Revenue Market Share by Type (2026-2031)
 Table 58. Global Oral Vaccine Delivery Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Oral Vaccine Delivery Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Oral Vaccine Delivery Sales (K Units) by Application (2020-2025)
 Table 61. Global Oral Vaccine Delivery Sales (K Units) by Application (2026-2031)
 Table 62. Global Oral Vaccine Delivery Sales Market Share by Application (2020-2025)
 Table 63. Global Oral Vaccine Delivery Sales Market Share by Application (2026-2031)
 Table 64. Global Oral Vaccine Delivery Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oral Vaccine Delivery Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oral Vaccine Delivery Revenue Market Share by Application (2020-2025)
 Table 67. Global Oral Vaccine Delivery Revenue Market Share by Application (2026-2031)
 Table 68. Global Oral Vaccine Delivery Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Oral Vaccine Delivery Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Oral Vaccine Delivery Product
 Table 74. Merck Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK Oral Vaccine Delivery Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Oral Vaccine Delivery Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Lanzhou Institute Company Information
 Table 86. Lanzhou Institute Description and Business Overview
 Table 87. Lanzhou Institute Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Lanzhou Institute Oral Vaccine Delivery Product
 Table 89. Lanzhou Institute Recent Developments/Updates
 Table 90. Serum Institute Company Information
 Table 91. Serum Institute Description and Business Overview
 Table 92. Serum Institute Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Serum Institute Oral Vaccine Delivery Product
 Table 94. Serum Institute Recent Developments/Updates
 Table 95. Valneva Company Information
 Table 96. Valneva Description and Business Overview
 Table 97. Valneva Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Valneva Oral Vaccine Delivery Product
 Table 99. Valneva Recent Developments/Updates
 Table 100. Shanghai United Cell Company Information
 Table 101. Shanghai United Cell Description and Business Overview
 Table 102. Shanghai United Cell Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shanghai United Cell Oral Vaccine Delivery Product
 Table 104. Shanghai United Cell Recent Developments/Updates
 Table 105. Bibcol Company Information
 Table 106. Bibcol Description and Business Overview
 Table 107. Bibcol Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bibcol Oral Vaccine Delivery Product
 Table 109. Bibcol Recent Developments/Updates
 Table 110. PaxVax Company Information
 Table 111. PaxVax Description and Business Overview
 Table 112. PaxVax Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. PaxVax Oral Vaccine Delivery Product
 Table 114. PaxVax Recent Developments/Updates
 Table 115. Vabiotech Company Information
 Table 116. Vabiotech Description and Business Overview
 Table 117. Vabiotech Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Vabiotech Oral Vaccine Delivery Product
 Table 119. Vabiotech Recent Developments/Updates
 Table 120. Tiantan Biological Company Information
 Table 121. Tiantan Biological Description and Business Overview
 Table 122. Tiantan Biological Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Tiantan Biological Oral Vaccine Delivery Product
 Table 124. Tiantan Biological Recent Developments/Updates
 Table 125. EuBiologics Company Information
 Table 126. EuBiologics Description and Business Overview
 Table 127. EuBiologics Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. EuBiologics Oral Vaccine Delivery Product
 Table 129. EuBiologics Recent Developments/Updates
 Table 130. Panacea Biotec Ltd Company Information
 Table 131. Panacea Biotec Ltd Description and Business Overview
 Table 132. Panacea Biotec Ltd Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Panacea Biotec Ltd Oral Vaccine Delivery Product
 Table 134. Panacea Biotec Ltd Recent Developments/Updates
 Table 135. Bio-Med Company Information
 Table 136. Bio-Med Description and Business Overview
 Table 137. Bio-Med Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Bio-Med Oral Vaccine Delivery Product
 Table 139. Bio-Med Recent Developments/Updates
 Table 140. Halfkin Bio-Pharmaceuticals Company Information
 Table 141. Halfkin Bio-Pharmaceuticals Description and Business Overview
 Table 142. Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Product
 Table 144. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Oral Vaccine Delivery Distributors List
 Table 148. Oral Vaccine Delivery Customers List
 Table 149. Oral Vaccine Delivery Market Trends
 Table 150. Oral Vaccine Delivery Market Drivers
 Table 151. Oral Vaccine Delivery Market Challenges
 Table 152. Oral Vaccine Delivery Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oral Vaccine Delivery
 Figure 2. Global Oral Vaccine Delivery Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oral Vaccine Delivery Market Share by Type: 2024 & 2031
 Figure 4. Rotavirus Vaccine Product Picture
 Figure 5. Cholera Vaccine Product Picture
 Figure 6. Oral Polio Vaccine Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Oral Vaccine Delivery Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Oral Vaccine Delivery Market Share by Application: 2024 & 2031
 Figure 10. Public
 Figure 11. Private
 Figure 12. Global Oral Vaccine Delivery Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Oral Vaccine Delivery Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Oral Vaccine Delivery Sales (2020-2031) & (K Units)
 Figure 15. Global Oral Vaccine Delivery Average Price (US$/Unit) & (2020-2031)
 Figure 16. Oral Vaccine Delivery Report Years Considered
 Figure 17. Oral Vaccine Delivery Sales Share by Manufacturers in 2024
 Figure 18. Global Oral Vaccine Delivery Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Oral Vaccine Delivery Players: Market Share by Revenue in Oral Vaccine Delivery in 2024
 Figure 20. Oral Vaccine Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Oral Vaccine Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Oral Vaccine Delivery Sales Market Share by Country (2020-2031)
 Figure 23. North America Oral Vaccine Delivery Revenue Market Share by Country (2020-2031)
 Figure 24. United States Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Oral Vaccine Delivery Sales Market Share by Country (2020-2031)
 Figure 27. Europe Oral Vaccine Delivery Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Oral Vaccine Delivery Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Oral Vaccine Delivery Revenue Market Share by Region (2020-2031)
 Figure 35. China Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Oral Vaccine Delivery Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Oral Vaccine Delivery Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Oral Vaccine Delivery Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Oral Vaccine Delivery Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Oral Vaccine Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Oral Vaccine Delivery by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Oral Vaccine Delivery by Type (2020-2031)
 Figure 54. Global Oral Vaccine Delivery Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Oral Vaccine Delivery by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Oral Vaccine Delivery by Application (2020-2031)
 Figure 57. Global Oral Vaccine Delivery Price (US$/Unit) by Application (2020-2031)
 Figure 58. Oral Vaccine Delivery Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS